Hubbard Cristin bought BMRN

March 16, 2026 · Form 4 insider transaction

Hubbard Cristin bought 36,680 shares of BioMarin Pharmaceutical Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.

Direction
Acquired (buy-side)
Shares
36,680
Price
$0.00
Total value
N/A
Role—
SecurityStock Option (Right to Buy Common Stock)
Transaction codeA: Grant or award
Transaction dateMarch 16, 2026
Filing dateMarch 18, 2026
Shares owned after36,680
OwnershipDirect
10b5-1 planNo
AmendedNo

Footnotes

Option grant vests 12/48th on March 16, 2027 and 1/48th on the 16th day of each month thereafter.

View the original Form 4 on SEC EDGAR